Tomorrow’s world
Walter Isaacson and Henry Greely probe the power and peril of CRISPR gene-editing MIT Press; 400 pages; $27.95 and £22.50
The Code Breaker. By Walter Isaacson.
Simon & Schuster; 560 pages; $35 and £30
W
HAT THE transistor once was to electronics, so
CRISPR gene-editing is to biotechnology today. It changes the field from something interesting but clunky, and of restricted application, into a game of infinite possibility that almost anyone can play. Transistors led to computer chips and the youthful entrepreneurs of the Homebrew Computer Club in Silicon Valley. Similarly,
CRISPR editing has let a new generation of would-be billionaires explore ideas that range from systematising the search for the proteins targeted by drugs, to breeding pigs that might act as organ donors for transplants.
Testing Information
COVID-19 testing is a requirement this semester and your on-campus privileges depend on you showing up for all of your tests.
Testing Program Overview
As mentioned in the Campus Guide, Bowdoin College has developed a testing protocol in partnership with the Broad Institute in Cambridge, Massachusetts, that is central to our return-to-campus plan. Per the Campus Community Agreement, students must comply with Bowdoin’s COVID-19 testing.
Test attendance will be tracked throughout the semester, and
students will be allowed one unexcused missed test. A student who misses three additional COVID-19 tests without prior written authorization will effectively opt out of the testing protocol and forfeit their on-campus privileges, including physically living on campus, and will move to remote learning for the remainder of the semester.
Posted on 346
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal
Nature Medicine that
used NanoString’s GeoMx® Digital Spatial Profiler (DSP) and the new Whole Transcriptome Atlas (WTA) to profile sarcoma tissue. The research was led by a team from the Broad Institute in Cambridge, Massachusetts. The paper, entitled “Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma,” can be found here.(https://www.nature.com/articles/s41591-020-01212-6)
Nature Medicine publishes first peer-reviewed study using GeoMx DSP with next generation sequencing readout. (Photo: Business Wire)
Press release content from Business Wire. The AP news staff was not involved in its creation.
Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas
February 9, 2021 GMT
Nature Medicine publishes first peer-reviewed study using GeoMx DSP with next generation sequencing readout. (Photo: Business Wire)
Nature Medicine publishes first peer-reviewed study using GeoMx DSP with next generation sequencing readout. (Photo: Business Wire)
SEATTLE (BUSINESS WIRE) Feb 9, 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal
Nature Medicine that
We re almost one week into the Biden administration, and already there are a slew of changes. I mean, the president signed 17 executive orders in his first hours in office alone.
To help make sense of it all, we asked WBUR reporters to dig into key issues of importance to Massachusetts: what changes are (or may be) coming under the Biden administration, and what they re watching out for in the weeks to come.
This explainer was created as a special edition of WBUR s daily morning newsletter, WBUR Today. To get more of the news Boston is talking about, sign up here.